Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 39,045 | 16,844 | N/A | N/A |
| TOTAL | $39,949 | $17,437 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3,037 | 801 | N/A | N/A |
| Other Non-Current Assets | 541 | 0 | 0 | 0 |
| TOTAL | $3,578 | $801 | $N/A | $N/A |
| Total Assets | $43,527 | $18,238 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 1,602 | 710 | 0 | 0 |
| Accrued Expenses | 1,757 | 1,155 | N/A | N/A |
| Other current liabilities | N/A | 56 | N/A | N/A |
| TOTAL | $3,359 | $1,921 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 19 | 0 | 0 |
| TOTAL | $N/A | $19 | $N/A | $N/A |
| Total Liabilities | $3,359 | $1,940 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Retained earnings | -42,511 | -15,988 | N/A | N/A |
| Other shareholders' equity | 81,658 | 31,816 | 0 | 0 |
| TOTAL | $40,168 | $16,298 | $N/A | $N/A |
| Total Liabilities And Equity | $43,527 | $18,238 | $0 | $0 |